Featured

For clinically stable outpatients with symptomatic COVID-19, neither aspirin nor apixaban reduced the rate of serious adverse cardiovascular or pulmonary events compared to placebo. COVID-19 … Read more

Research has found that Asthma affects around 25 million people in the United States. This equates to around one in every thirteen Americans, including 8% … Read more

Type 1 diabetes affects 1.6 million people in the United States, including 200,000 young people (under the age of 20) and 1.4 million adults (20 … Read more

As we know, scientific researchers have lengthy analyzed cellular adjustments in the body over time, fresh research led by a team in which researchers look … Read more

Cancer treatments were supposed to either increase the average lifespan or maintain the comfort of living. The fast clearance procedure is used to bring several … Read more

The advent of novel SARS-CoV-2 variants with the potential to spread quickly and impair vaccine-induced immunity poses a risk to the COVID-19 pandemic’s conclusion. The … Read more

COVID-19 is prevalent not just amongst workers in the healthcare and socio-economic services industries but also is common in occupations with poor pay, minimal education … Read more

The study discovered a relationship among type 1 diabetes with alterations as in gut microbiome linked to intestine inflammatory; this can explain why females with … Read more

The stem cell treatment has been tested by key scientific organizations throughout the world, including those in China and the United States. Some people have experienced … Read more

Immune system illnesses are illnesses where our invulnerable framework harms the body and is developing, yet we think minimal about what triggers them. Specialists are … Read more